S&P 500   4,071.70 (-0.12%)
DOW   34,429.88 (+0.10%)
QQQ   292.55 (-0.40%)
AAPL   147.81 (-0.34%)
MSFT   255.02 (+0.13%)
META   123.49 (+2.53%)
GOOGL   100.44 (-0.54%)
AMZN   94.13 (-1.43%)
TSLA   194.86 (+0.08%)
NVDA   168.76 (-1.51%)
NIO   13.13 (+8.60%)
BABA   90.06 (+4.79%)
AMD   74.98 (-3.23%)
T   19.02 (-0.89%)
MU   54.68 (-1.46%)
CGC   4.29 (+9.16%)
F   13.86 (-1.56%)
GE   86.88 (+1.90%)
DIS   99.43 (+0.85%)
AMC   8.17 (+0.00%)
PYPL   74.66 (-4.93%)
PFE   50.91 (-0.33%)
NFLX   320.41 (+1.09%)
S&P 500   4,071.70 (-0.12%)
DOW   34,429.88 (+0.10%)
QQQ   292.55 (-0.40%)
AAPL   147.81 (-0.34%)
MSFT   255.02 (+0.13%)
META   123.49 (+2.53%)
GOOGL   100.44 (-0.54%)
AMZN   94.13 (-1.43%)
TSLA   194.86 (+0.08%)
NVDA   168.76 (-1.51%)
NIO   13.13 (+8.60%)
BABA   90.06 (+4.79%)
AMD   74.98 (-3.23%)
T   19.02 (-0.89%)
MU   54.68 (-1.46%)
CGC   4.29 (+9.16%)
F   13.86 (-1.56%)
GE   86.88 (+1.90%)
DIS   99.43 (+0.85%)
AMC   8.17 (+0.00%)
PYPL   74.66 (-4.93%)
PFE   50.91 (-0.33%)
NFLX   320.41 (+1.09%)
S&P 500   4,071.70 (-0.12%)
DOW   34,429.88 (+0.10%)
QQQ   292.55 (-0.40%)
AAPL   147.81 (-0.34%)
MSFT   255.02 (+0.13%)
META   123.49 (+2.53%)
GOOGL   100.44 (-0.54%)
AMZN   94.13 (-1.43%)
TSLA   194.86 (+0.08%)
NVDA   168.76 (-1.51%)
NIO   13.13 (+8.60%)
BABA   90.06 (+4.79%)
AMD   74.98 (-3.23%)
T   19.02 (-0.89%)
MU   54.68 (-1.46%)
CGC   4.29 (+9.16%)
F   13.86 (-1.56%)
GE   86.88 (+1.90%)
DIS   99.43 (+0.85%)
AMC   8.17 (+0.00%)
PYPL   74.66 (-4.93%)
PFE   50.91 (-0.33%)
NFLX   320.41 (+1.09%)
S&P 500   4,071.70 (-0.12%)
DOW   34,429.88 (+0.10%)
QQQ   292.55 (-0.40%)
AAPL   147.81 (-0.34%)
MSFT   255.02 (+0.13%)
META   123.49 (+2.53%)
GOOGL   100.44 (-0.54%)
AMZN   94.13 (-1.43%)
TSLA   194.86 (+0.08%)
NVDA   168.76 (-1.51%)
NIO   13.13 (+8.60%)
BABA   90.06 (+4.79%)
AMD   74.98 (-3.23%)
T   19.02 (-0.89%)
MU   54.68 (-1.46%)
CGC   4.29 (+9.16%)
F   13.86 (-1.56%)
GE   86.88 (+1.90%)
DIS   99.43 (+0.85%)
AMC   8.17 (+0.00%)
PYPL   74.66 (-4.93%)
PFE   50.91 (-0.33%)
NFLX   320.41 (+1.09%)
NYSE:MCK

McKesson - MCK Stock Forecast, Price & News

$386.85
+7.13 (+1.88%)
(As of 12/2/2022 05:07 PM ET)
Add
Compare
Today's Range
$377.80
$389.45
50-Day Range
$339.87
$397.58
52-Week Range
$217.03
$401.78
Volume
1.04 million shs
Average Volume
1.11 million shs
Market Capitalization
$54.85 billion
P/E Ratio
27.30
Dividend Yield
0.57%
Price Target
$395.91

McKesson MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
2.3% Upside
$395.91 Price Target
Short Interest
Healthy
1.76% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.01
Upright™ Environmental Score
News Sentiment
0.51mentions of McKesson in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
$9.11 M Sold Last Quarter
Proj. Earnings Growth
6.71%
From $24.75 to $26.41 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.48 out of 5 stars

Medical Sector

189th out of 1,052 stocks

Drugs, Proprietaries, & Sundries Industry

4th out of 7 stocks

MCK stock logo

About McKesson (NYSE:MCK) Stock

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Receive MCK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for McKesson and its competitors with MarketBeat's FREE daily newsletter.

MCK Stock News Headlines

Top Healthcare Stocks
3 Warren Buffett Stocks to Buy Hand Over Fist Before 2023
McKesson PT Raised to $450 at Jefferies
15 Biggest Multinational Companies in the World
See More Headlines
Receive MCK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for McKesson and its competitors with MarketBeat's FREE daily newsletter.

MCK Company Calendar

Last Earnings
10/31/2021
Ex-Dividend for 10/3 Dividend
8/31/2022
Dividend Payable
10/03/2022
Ex-Dividend for 1/3 Dividend
11/30/2022
Today
12/02/2022
Dividend Payable
1/03/2023
Next Earnings (Estimated)
2/01/2023
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Health Care Distributors
Sector
Medical
CUSIP
58155Q10
Employees
75,000
Year Founded
1833

Price Target and Rating

Average Stock Price Forecast
$395.91
High Stock Price Forecast
$440.00
Low Stock Price Forecast
$265.00
Forecasted Upside/Downside
+2.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

Net Income
$1.11 billion
Pretax Margin
1.17%

Debt

Sales & Book Value

Annual Sales
$263.97 billion
Cash Flow
$31.97 per share
Book Value
($8.81) per share

Miscellaneous

Free Float
141,495,000
Market Cap
$54.85 billion
Optionable
Optionable
Beta
0.63

Social Links


Key Executives

  • Mr. Brian S. Tyler Ph.D.Mr. Brian S. Tyler Ph.D. (Age 55)
    CEO & Director
    Comp: $5.9M
  • Mr. Britt J. VitaloneMr. Britt J. Vitalone (Age 53)
    Exec. VP & CFO
    Comp: $2.63M
  • Ms. Nancy FloresMs. Nancy Flores (Age 54)
    Exec. VP, Chief Information Officer & CTO
    Comp: $1.6M
  • Ms. Lori A. Schechter J.D.Ms. Lori A. Schechter J.D. (Age 60)
    Exec. VP, Chief Legal Officer & Gen. Counsel
    Comp: $2.66M
  • Ms. Tracy L. FaberMs. Tracy L. Faber (Age 52)
    Exec. VP & Chief HR Officer
    Comp: $1.83M
  • Mr. Napoleon B. Rutledge Jr. (Age 50)
    Sr. VP, Controller & Chief Accounting Officer
  • Ms. Holly Weiss
    Sr. VP of Investor Relations
  • Mr. Pete Slone
    Sr. VP of Corp. Public Affairs
  • Mr. Kirk Kaminsky
    Pres of The US Pharmaceutical & Specialty Solutions Bus.
  • Paul A. Smith
    Sr. VP of Taxes













MCK Stock - Frequently Asked Questions

Should I buy or sell McKesson stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MCK shares.
View MCK analyst ratings
or view top-rated stocks.

What is McKesson's stock price forecast for 2023?

10 brokerages have issued twelve-month price targets for McKesson's shares. Their MCK share price forecasts range from $265.00 to $440.00. On average, they expect the company's share price to reach $395.91 in the next twelve months. This suggests a possible upside of 2.3% from the stock's current price.
View analysts price targets for MCK
or view top-rated stocks among Wall Street analysts.

How have MCK shares performed in 2022?

McKesson's stock was trading at $248.57 at the beginning of 2022. Since then, MCK stock has increased by 55.8% and is now trading at $387.16.
View the best growth stocks for 2022 here
.

Are investors shorting McKesson?

McKesson saw a increase in short interest in October. As of October 31st, there was short interest totaling 2,980,000 shares, an increase of 8.8% from the October 15th total of 2,740,000 shares. Based on an average daily trading volume, of 954,700 shares, the short-interest ratio is presently 3.1 days. Currently, 2.1% of the company's stock are sold short.
View McKesson's Short Interest
.

When is McKesson's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our MCK earnings forecast
.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) announced its quarterly earnings results on Sunday, October, 31st. The company reported $6.15 earnings per share for the quarter, beating analysts' consensus estimates of $4.66 by $1.49. The firm had revenue of $66.58 billion for the quarter, compared to analysts' expectations of $63.23 billion. McKesson had a net margin of 0.76% and a negative trailing twelve-month return on equity of 267.09%. McKesson's quarterly revenue was up 9.5% on a year-over-year basis. During the same period in the previous year, the firm posted $4.80 EPS.
Read the conference call transcript
.

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson announced a quarterly dividend on Wednesday, October 26th. Investors of record on Thursday, December 1st will be paid a dividend of $0.54 per share on Tuesday, January 3rd. This represents a $2.16 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date of this dividend is Wednesday, November 30th.
Read our dividend analysis for MCK
.

Is McKesson a good dividend stock?

McKesson (NYSE:MCK) pays an annual dividend of $2.16 per share and currently has a dividend yield of 0.57%. The company has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 15.24%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MCK will have a dividend payout ratio of 8.18% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MCK.

How will McKesson's stock buyback program work?

McKesson declared that its Board of Directors has initiated a stock repurchase program on Tuesday, February 2nd 2021, which allows the company to buyback $2,000,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to repurchase up to 6.9% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's management believes its shares are undervalued.

What guidance has McKesson issued on next quarter's earnings?

McKesson issued an update on its FY 2023 earnings guidance on Tuesday, November, 8th. The company provided earnings per share (EPS) guidance of $24.45-$24.95 for the period, compared to the consensus earnings per share estimate of $24.50. The company issued revenue guidance of $271.88 billion-$282.44 billion, compared to the consensus revenue estimate of $276.54 billion.

What is Brian Tyler's approval rating as McKesson's CEO?

220 employees have rated McKesson Chief Executive Officer Brian Tyler on Glassdoor.com. Brian Tyler has an approval rating of 88% among the company's employees.

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (DIS), Johnson & Johnson (JNJ), Gilead Sciences (GILD), CVS Health (CVS), AbbVie (ABBV), Bank of America (BAC), AT&T (T), JPMorgan Chase & Co. (JPM), UnitedHealth Group (UNH) and Home Depot (HD).

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

Who are McKesson's major shareholders?

McKesson's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (10.72%), BlackRock Inc. (7.90%), State Street Corp (4.62%), Massachusetts Financial Services Co. MA (3.37%), Putnam Investments LLC (1.43%) and Bank of New York Mellon Corp (1.27%). Insiders that own company stock include Brian S Tyler, Brian S Tyler, Britt J Vitalone, Kevin Emerson, Lori A Schechter, Lori A Schechter, Marie L/Ca Knowles, Nancy Flores, Sundeep G Reddy, Sundeep G Reddy, Thomas L Rodgers, Thomas L Rodgers and Tracy Faber.
View institutional ownership trends
.

How do I buy shares of McKesson?

Shares of MCK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $387.16.

How much money does McKesson make?

McKesson (NYSE:MCK) has a market capitalization of $54.90 billion and generates $263.97 billion in revenue each year. The company earns $1.11 billion in net income (profit) each year or $14.17 on an earnings per share basis.

How many employees does McKesson have?

The company employs 75,000 workers across the globe.

Does McKesson have any subsidiaries?
The following companies are subsidiares of McKesson: A.L.I. Technologies, AMISYS Managed Care Systems, Abaton.com, Access Health, Biologics, Celesio, CoverMyMeds, D & K Healthcare Resources, Drug Trading Co. Ltd., EN-Chart Scanning Program, Echo, Emendo, Enterprise Systems Inc., HBO & Company, HPR, HealthCom Partners, HealthQx, IMNET Systems, LloydsDirect, MED3000, McKesson Europe AG, McKesson Europe Holdings GmbH & Co. KGaA, McKesson Global Procurement & Sourcing Limited, McKesson International Bermuda IP2A Limited, McKesson International Bermuda IP3A Limited, McKesson Ireland Limited, McKesson Medical-Surgical Holdings Inc., McKesson Medical-Surgical Inc., McKesson Medical-Surgical Supply Chain Services LLP, McKesson Medical-Surgical Top Holdings Inc., McKesson Plasma and Biologics LLC, McKesson Specialty Care Distribution LLC, McKesson UK Finance I Limited, McKesson UK Finance II Limited, McKesson US Finance Corporation, McQueary Brothers, MedVentive, Medcon, MediVation Inc., Medical Specialties Distributors, Medis Health And Pharmaceutical Services, Moore Medical, NDCHealth, Oncology Therapeutics Network, PSS World Medical, Per-Se Technologies, Portico Systems, Practice Partner, RedLine HealthCare, RelayHealth, Rexall, Rosebud Solutions, RxCrossroads, Sterling Medical Services LLC, UDG Healthcare, US Oncology, US Oncology Holdings Inc., US Oncology Inc., United Drug (Wholesale) Limited, United Drug Distributors Ireland Limited, Vantage Oncology, Vivalog Technologies, Well.ca, and peerVue.
Read More
How can I contact McKesson?

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The official website for the company is www.mckesson.com. The company can be reached via phone at (972) 446-4800, via email at investors@mckesson.com, or via fax at 415-983-8453.

This page (NYSE:MCK) was last updated on 12/2/2022 by MarketBeat.com Staff